Structure Based Drug Design
Stout TJ, et al. Structure-based design of inhibitors specific for bacterial
thymidylate synthase. Biochemistry. 1999 Feb 2;38(5):1607-17.
Frecer V, Miertus S, Tossi A, Romeo D Drug Des Discov 1998 Oct;15(4):211-31. Rational design of inhibitors for drug-resistant HIV-1 aspartic protease mutants.
Kirkpatrick DL, Watson S, Ulhaq S Comb Chem High Throughput Screen 1999 2:211-21. (Pub) Structure-based drug design: combinatorial chemistry and molecular modeling.
Guo et al. Science 2000 288:2042-5. Designing small-molecule switches for protein-protein interactions. (Pub)
Lee et al. PNAS 1998 95:939-44. Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, & HIV in vitro & ex vivo. (Pub)